Webinar Archive
Our 2009 Webinar Series explains the applications of Veratag technology and profiles the HERmark Breast Cancer Assay as an accurate measure of HER2 total and homodimer expression. The webinars listed below are available to download. Each presentation is approximately 20 minutes and includes recent published data.
2009
|
HERMARK BASED ON VERATAG TECHNOLOGY: A NEW PLATFORM FOR QUANTIFYING THE HER FAMILY OF RECEPTORS
|
|
||||
Featured Speaker: Sunil Badve, MB, Director of Translational Genomics Core, Indiana University |
|||||
Dr. Badve reviews the recent publications detailing the VeraTag technology method and early clinical data using the HERmark assay. |
|||||
| Click Here to download the video | |||||
|
INTRODUCTION TO HERMARK AND LIPTON (SABCS 2008) COHORT DATA ANALYSIS
|
|
||||
Featured Speaker: Michael Bates, MD |
|||||
In this webinar, Dr. Bates introduces the use of VeraTag technology to analyze samples from the Hershey/Vienna cohort, where HERmark outperformed current HER2 testing methods. |
|||||
| Click Here to download the video | |||||
|
VERATAG TECHNOLOGY AND APPLICATIONS |
|
||||
Featured Speaker: Laurie Goodman, PhD |
|||||
Dr. Goodman provides an in-depth description of how VeraTag utilizes dual-antibody technology to measure proteins, and how it can be used to measure other HER family proteins such as HER3 and p95. |
|||||
| Click Here to download the video | |||||
